It was reported on Tuesday that the European Commission has granted final approval to US-based companies Mylan (NASDAQ: MYL) and Pfizer Inc (NYSE: PFE) for the proposed combination of their Upjohn business.
The European Commission offered conditional approval in April 2020 that was subject to the divestiture of certain of Mylan's products in Europe.
The European Commission approved the proposed divestiture buyers and Mylan signed the contract with those customers on terms that the European Commission has accepted. Both firms have already received approval from the Australian Competition and Consumer Commission and the New Zealand Commerce Commission related to combining this business.
United Sewing Automation passes test results of NC-manufactured PPE surgical masks
Parnell Pharmaceuticals develops antiviral nasal spray
Quadrant Biosciences wins FDA's EUA for new saliva swab for Covid-19 testing
NeuroRx files for FDA's EUA for RLF-100 in the treatment of patients with critical COVID-19